Probi AB Email Format
Biotechnology ResearchGävleborg, Sweden51-200 Employees
Probi AB operates in biotechnology, offering biotics solutions centered on probiotics and related ingredients for supplements and functional foods. Originating at Lund University in 1991, the company serves more than 40 markets worldwide and holds a portfolio of global patents. In 2025, Probi was acquired by Symrise AG, situating it within a broader health and beauty portfolio and expanding its global reach. The business focuses on researching, manufacturing, and supplying probiotic and postbiotic ingredients to support gut microbiome health and metabolic health outcomes. It collaborates with customers and research partners to develop future-ready formulations, including recent developments such as a postbiotic variant of Lacticaseibacillus rhamnosus 271 (Rham271h). It has pursued international expansion through partnerships, notably bringing LP299V to Japan through a collaboration with Nomura Dairy Products.